daptomycin


Also found in: Medical, Wikipedia.
Related to daptomycin: vancomycin
Translations

daptomycin

n daptomicina
References in periodicals archive ?
Although cefazolin is the first choice in most of the current guidelines for the treatment of MSSA bacteraemia in the case of unavailability of anti-staphylococcal penicillins (ASP) like being in our country, other beta-lactams including ampicillin-sulbactam or other cephalosporins, glycopeptides and daptomycin are also used frequently (9).
The second study, ERADICATE, which compares ceftobiprole to daptomycin with or without aztreonam in the treatment of patients with Staphylococcus aureus bacteremia (SAB), is ongoing and topline results are expected in the second half of 2021.2 Both studies are required for an NDA of ceftobiprole in the U.S.
Lipopeptide accounted for highest market share in 2016, owing to the diversified distribution of daptomycin (lipopeptide) across the globe by key distributors in 2016.
Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness.
BUFFALO GROVE Xellia Pharmaceuticals has signed an agreement with Civica Rx to manufacture Civica antibiotics, including Vancomycin and Daptomycin, for Civica's member health systems.
Recently, the LUMC ASP implemented a policy that mandates an ID evaluation or consultation for patients with Staphylococcus aureus bacteremia, carbapenem-resistant Enterobacteriaceae (CRE) infections (except urinary isolates), Candida auris infections, fungemia, nocardiosis, mucormycosis, cryptococcosis, multidrug-resistant (MDR) bacteremia from any of the following pathogens: daptomycin and vancomycin-resistant enterococci, daptomycin-resistant S.
In an animal model of Staph aureus infection, PAE resulted in bacterial growth delays of 19 hours and extended growth delays by 6 hours in the presence of daptomycin. These data suggest that sub-MIC concentrations of exebacase during therapeutic use in addition to standard of care antibiotics, may contribute to efficacy via sustained reductions in bacterial fitness and virulence.
Post culture treatments associated with lower mortality rate included the use of daptomycin, carbapenems and polymyxin B.
To be included, patients must have had a microbiologically confirmed MRSA cSSTI (e.g., deep or extensive cellulitis, infected wound or ulcer, major abscess or other soft tissue infection requiring substantial surgical intervention), and received [greater than or equal to]3 days of IV anti-MRSA antibiotics including, but not limited to: clindamycin, daptomycin, fusidic acid, linezolid, rifampicin, teicoplanin, tigecycline, TMP/SMX, or vancomycin, during their hospital stay.
The initial therapy was acyclovir 10 mg/kg provided thrice a day and 4 mg/kg daptomycin. Ophthalmologic examination showed herpetic lesions on the cornea, and topical ganciclovir application was also added to the initial therapy.
daptomycin (plus optional aztreonam for Gram-negative infections) in the treatment of SAB.